Rebalancing the Oral Microbiota as an Efficient Tool in Endocrine, Metabolic and Immune Disorders

Endocr Metab Immune Disord Drug Targets. 2021;21(5):777-784. doi: 10.2174/1871530320666200729142504.

Abstract

The current treatment and prevention procedures of oral disorders follow a very targeted approach considering mouth and its structures as a system that is completely independent, than the rest of the body. The main therapeutic approach is to keep the levels of oral bacteria and hygiene in an acceptable range compatible with oral-mouth health, completely separated from systemic microbial homeostasis (eubiosis vs dysbiosis). This can negatively impact the diagnosis of a more complex systemic disease and its progression. Dysbiosis occurs as a consequence of imbalance in oral and gut microbiota which leads to cardiovascular diseases, diabetes mellitus, rheumatoid arthritis, and Alzheimer's disease, as reported in current literature. Likewise, there is a need to highlight and develop a novel philosophical approach in the treatments for oral diseases that will necessarily involve nonconventional approaches.

Keywords: Periodontal disease; central nervous system (CNS) diseases; gut dysbiosis; macrophages; oral dysbiosis; probiotics.

Publication types

  • Review

MeSH terms

  • Animals
  • Dysbiosis / microbiology*
  • Dysbiosis / therapy
  • Endocrine System Diseases / microbiology*
  • Endocrine System Diseases / therapy
  • Fatty Acids / administration & dosage
  • Fatty Acids / adverse effects
  • Gastrointestinal Microbiome* / drug effects
  • Gastrointestinal Microbiome* / physiology
  • Gastrointestinal Tract
  • Humans
  • Immune System Diseases / microbiology*
  • Immune System Diseases / therapy
  • Metabolic Diseases / microbiology*
  • Metabolic Diseases / therapy
  • Microbiota / drug effects
  • Microbiota / physiology
  • Mouth Mucosa / microbiology*
  • Mouth Mucosa / physiology
  • Probiotics / administration & dosage

Substances

  • Fatty Acids